Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Rosti

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 20, 2019
Nutritional support in cancer patients: reply to Scarpi et alPaolo Pedrazzoli, Carmine Pinto, Giovanni Rosti, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 6, 2018
Reply to: Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy: a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO)Riccardo Caccialanza, Giovanni Rosti, Ornella Carminati, et al.
Haematologica|January 22, 2002
The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patientsUgo De Giorgi, Giovanni Rosti, Giorgio Papiani, et al.
Tumori|August 28, 2002
High-dose chemotherapy in small cell lung cancerFelice Pasini, Giuseppe Pelosi, Giovanni De Manzoni, et al.
Tumori|July 8, 2009
Cost-effectiveness of pegfilgrastim versus six days of filgrastim for preventing febrile neutropenia in breast cancer patientsMarco Danova, Silvia Chiroli, Giovanni Rosti, et al.
Critical Reviews in Oncology/Hematology|January 25, 2021
Serum tumour markers in germ cell tumours: From diagnosis to curePaolo Pedrazzoli, Giovanni Rosti, Eleonora Soresini, et al.
Medical Oncology (Northwood, London, England)|June 28, 2017
Salvage treatment for testicular cancer with standard- or high-dose chemotherapy: a systematic review of 59 studiesFausto Petrelli, Andrea Coinu, Giovanni Rosti, et al.
Seminars in Oncology|May 12, 2019
Primary mediastinal germ cell tumorsGiovanni Rosti, Simona Secondino, Andrea Necchi, et al.
Seminars in Hematology|October 27, 2007
High-dose chemotherapy with autologous hematopoietic stem cell support for solid tumors in adultsPaolo Pedrazzoli, Giovanni Rosti, Simona Secondino, et al.
Oncology Reports|November 8, 2005
Use of granulocyte colony-stimulating factor: a survey among Italian medical oncologistsMarco Danova, Giovanni Rosti, Sabino De Placido, et al.
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 20, 2019
Nutritional support in cancer patients: reply to Scarpi et alPaolo Pedrazzoli, Carmine Pinto, Giovanni Rosti, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 6, 2018
Reply to: Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy: a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO)Riccardo Caccialanza, Giovanni Rosti, Ornella Carminati, et al.
Haematologica|January 22, 2002
The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patientsUgo De Giorgi, Giovanni Rosti, Giorgio Papiani, et al.
Tumori|August 28, 2002
High-dose chemotherapy in small cell lung cancerFelice Pasini, Giuseppe Pelosi, Giovanni De Manzoni, et al.
Tumori|July 8, 2009
Cost-effectiveness of pegfilgrastim versus six days of filgrastim for preventing febrile neutropenia in breast cancer patientsMarco Danova, Silvia Chiroli, Giovanni Rosti, et al.
Critical Reviews in Oncology/Hematology|January 25, 2021
Serum tumour markers in germ cell tumours: From diagnosis to curePaolo Pedrazzoli, Giovanni Rosti, Eleonora Soresini, et al.
Medical Oncology (Northwood, London, England)|June 28, 2017
Salvage treatment for testicular cancer with standard- or high-dose chemotherapy: a systematic review of 59 studiesFausto Petrelli, Andrea Coinu, Giovanni Rosti, et al.
Seminars in Oncology|May 12, 2019
Primary mediastinal germ cell tumorsGiovanni Rosti, Simona Secondino, Andrea Necchi, et al.
Seminars in Hematology|October 27, 2007
High-dose chemotherapy with autologous hematopoietic stem cell support for solid tumors in adultsPaolo Pedrazzoli, Giovanni Rosti, Simona Secondino, et al.
Oncology Reports|November 8, 2005
Use of granulocyte colony-stimulating factor: a survey among Italian medical oncologistsMarco Danova, Giovanni Rosti, Sabino De Placido, et al.
Pageof 9